Skip to content
StockMarketAgent
Sector pending / Laboratory Analytical InstrumentsUpdated 2026-05-10 22:07 UTC

FRA/BUWA stock hub

FRA/BUWA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/BUWAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
5.8B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/BUWA
In the news

Latest news · FRA/BUWA

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.7
P25 n/aP50 n/aP75 n/a
Trailing P/E39.5
P25 n/aP50 n/aP75 n/a
ROE2.5
P25 n/aP50 n/aP75 n/a
ROIC3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/BUWA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
213
Groups with data
11
Currency
USD
Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
7,450
Employees Change
-250%
Employees Change Percent
-3.25
Enterprise value
EUR 5.6B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Laboratory Analytical Instruments
Last refreshed
2026-05-10
Market cap
EUR 5.8B
Price
EUR 217
Price currency
EUR
Rev Per Employee
301,506.08x
Sic
3826
Symbol
fra/BUWA
Website
https://www.bio-rad.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
2.53%
EV Earnings
38.45x
EV/EBIT
23.95x
EV/EBITDA
12.93x
EV/FCF
18.17x
EV/Sales
2.56x
FCF yield
5.35%
Forward P/E
25.65x
P/B ratio
0.97x
P/E ratio
39.53x
P/S ratio
2.58x
PE Ratio10 Y
65.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

21
MetricValue
EBIT Margin
10.68%
EBITDA Margin
17.17%
FCF margin
13.79%
Gross margin
52.01%
Gross Profit
EUR 1.2B
Gross Profit Growth
-1.92%
Gross Profit Growth Q
1.11%
Gross Profit Growth3 Y
-4.12%
Gross Profit Growth5 Y
-2.4%
Net Income
EUR 146.4M
Net Income Growth5 Y
-47.16%
Pretax Margin
8.58%
Profit Margin
6.52%
Profit Per Employee
EUR 19,651
ROA
1.79
Roa5y
1.87
ROCE
3.12
ROE
2.5
Roe5y
-3.05
ROIC
3.01
Roic5y
3.87

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

20
MetricValue
Cagr10y
5.74%
Cagr15y
6.57%
Cagr1y
6.99%
Cagr20y
7.41%
Cagr3y
-19.12%
Cagr5y
-15.14%
EPS Growth5 Y
-46
FCF Growth
0.48%
FCF Growth Q
-18.22%
FCF Growth3 Y
41.31%
FCF Growth5 Y
-7.56%
OCF Growth
-0.95%
OCF Growth Q
-16.78%
OCF Growth10 Y
13.08%
OCF Growth3 Y
28.24%
OCF Growth5 Y
-4%
Revenue Growth
1.92x
Revenue Growth Q
1.15x
Revenue Growth3 Y
-2.32x
Revenue Growth5 Y
-0.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 0.27
Assets
EUR 8.5B
Cash
EUR 1.4B
Current Assets
EUR 2.5B
Current Liabilities
EUR 777.6M
Debt
EUR 1.2B
Debt EBITDA
EUR 2.69
Debt Equity
EUR 0.2
Debt FCF
EUR 3.86
Equity
EUR 5.9B
Interest Coverage
5.61
Liabilities
EUR 2.5B
Long Term Assets
EUR 6B
Long Term Liabilities
EUR 1.8B
Net Cash
EUR 161.8M
Net Cash By Market Cap
EUR 2.79
Net Cash Growth
-35.89%
Net Debt EBITDA
EUR -0.42
Net Debt Equity
EUR -0.03
Net Debt FCF
EUR -0.52
Tangible Book Value
EUR 5.3B
Tangible Book Value Per Share
EUR 197

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.21
Inventory Turnover
1.59
Net Working Capital
EUR 778.1M
Quick ratio
2.19
Working Capital
EUR 1.8B
Working Capital Turnover
EUR 0.99

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
3.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
74.65%
1Y total return
6.99%
200-day SMA
249.6
3Y total return
-47.1%
50-day SMA
236.4
50-day SMA vs 200-day SMA
50under200
5Y total return
-55.99%
All Time High
700
All Time High Change
-68.94%
All Time High Date
2021-09-13
All Time Low
18.15
All Time Low Change
1,097.8%
All Time Low Date
2001-03-26
ATR
7.39
Ch YTD
-15.01
High
218
High52
294.7
High52 Date
2025-10-27
High52ch
-26.23%
Low
213.2
Low52
187.4
Low52 Date
2025-06-03
Low52ch
16.04%
Ma50ch
-8.03%
Price vs 200-day SMA
-12.91%
RSI
33.93
RSI Monthly
39.95
RSI Weekly
40.44
Sharpe ratio
0.09x
Sortino ratio
0.28
Total Return
3.69%
Tr YTD
-15.01
Tr15y
159.68%
Tr1m
-8.89%
Tr1w
-1.18%
Tr3m
-14.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 239.9M
Operating Income Growth
5.9
Operating Income Growth Q
43.88
Operating Income Growth3 Y
-11.74
Operating Income Growth5 Y
-8.76
Operating margin
10.68

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
20,902,420%
Net Borrowing
-423,981
Shares Insiders
6.55%
Shares Institutions
74.33%
Shares Qo Q
-0.2%
Shares Yo Y
-3.69%
Short Ratio
3.22

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

64
MetricValue
Adjusted FCF
EUR 259.8M
Average Volume
3x
Bv Per Share
221.5
CAPEX
EUR -132.9M
Ch10y
74.65
Ch15y
159.7
Ch1m
-8.89
Ch1w
-1.18
Ch1y
6.99
Ch20y
318
Ch3m
-14.81
Ch3y
-47.1
Ch5y
-55.99
Ch6m
-17.46
Change
-0.73%
Change From Open
-0.28
Close
219
Days Gap
-0.46
Depreciation Amortization
142,627,208.4
Earnings Date
2026-04-30
EBIT
EUR 239.9M
EBITDA
EUR 385.8M
EPS
EUR 5.41
F Score
6
FCF
EUR 309.8M
FCF EV Yield
5.5x
Financing CF
-199,045,350
Fiscal Year End
December
Founded
1,952
Goodwill
489,358,870.2
Graham Number
166.18505
Graham Upside
-23.56
Income Tax
EUR 46.4M
Investing CF
-247,874,340
Is Primary Listing
0
Last Earnings Date
2026-04-30
Last Report Date
2026-03-31
Last Split Date
2002-03-08
Last Split Type
Forward
Lynch Fair Value
EUR 27.5
Lynch Upside
-87.35
Ma150
253.7
Ma150ch
-14.32%
Ma20
239.8
Ma20ch
-9.34%
Net CF
-12,228,930
Open
218
P FCF Ratio
18.68
P OCF Ratio
13.07
Position In Range
87.5
Ppne
584,585,002.8
Price Date
2026-05-08
Price EBITDA
EUR 15
Ptbv Ratio
1.09
Relative Volume
20x
Revenue
2,246,220,270x
SBC By Revenue
2.23x
Share Based Comp
50,043,210
Tax By Revenue
2.07x
Tax Rate
24.07%
Tr20y
318%
Tr6m
-17.46%
Volume
0
Z Score
3.23
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/BUWA pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/BUWA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+7.0%
S&P 500 1Y: n/a
3Y total return
-47.1%
S&P 500 3Y: n/a
5Y total return
-56.0%
S&P 500 5Y: n/a
10Y total return
+74.6%
S&P 500 10Y: n/a
Ownership

Who owns FRA/BUWA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+74.3%
Share of float held by funds and institutions
Insider ownership
+6.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
3.2 days to cover
Y/Y dilution
-3.7%
Negative means the company is buying back shares.
Technical

FRA/BUWA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
33.9
Neutral momentum band
Price vs 200-day MA
-12.9%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.09
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/BUWA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/BUWA stock rating?

fra/BUWA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/BUWA analysis?

The full report lives at /stocks/fra/BUWA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/BUWA?

The latest report frames fra/BUWA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/BUWA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

fra/BUWA stock profile: metrics, valuation and analysis | 股票市场 AI 助手